Anaplastic lymphoma kinase
RxNorm 75090
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 75090 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Anaplastic lymphoma kinase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
ALK tyrosine kinase receptor
(Atom ID: 12754489)
FN
Full form of descriptor (FN):
ALK tyrosine kinase receptor (substance)
(Atom ID: 12754490)
SY
Synonym (SY):
Anaplastic lymphoma kinase
(Atom ID: 12754714)
SY
Synonym (SY):
CD246 (cluster of differentiation 246) antigen
(Atom ID: 12755039)
SY
Synonym (SY):
CD246 - cluster of differentiation 246
(Atom ID: 12755040)
SY
Synonym (SY):
Cluster of differentiation 246
(Atom ID: 12755229)
SY